Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Friday, December 24, 2021

Upstream Bioprocessing Market is anticipated to grow at a CAGR of 12%-14% during 2020-2025

The global upstream bioprocessing market is projected to grow at a CAGR of 12%-14% during 2020-2025. The growth of upstream bioprocessing market is driven by increasing prevalence of chronic diseases, rising research activities for development of biosimilar/biomolecules, small therapeutic peptide and monoclonal antibodies, and growing demand for process optimization and contamination free, safe and efficient production of biomolecules.

Some of the Key Questions answered in this exclusive report are:

Q.1 What are some of the most promising, high-growth opportunities for the upstream bioprocessing market by product (cell culture products, bioreactors/fermenters, filters, bags & containers, bioreactor accessories and others), workflow (cell culture, media preparation, and cell separation), use type (single-use and multi-use), mode (outsourced and in-house), and region (North America, Europe, Asia Pacific, and Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 What are the business risks and threats to the upstream bioprocessing market?

Q.4 What are some changing demands of customers in the upstream bioprocessing market?

Q.5 What are the new developments in the upstream bioprocessing market? Which companies are leading these developments?

Q.6 What strategic initiatives are being implemented by key players for business growth?

Q.7 What are some of the competitive products and processes in this upstream bioprocessing area and how big of a threat do they pose for loss of market share via product substitution?

Q.8 What M&A activity has occurred in the last 5 years in this upstream bioprocessing market?

Download Brochure of this report by clicking on https://www.lucintel.com/upstream-bioprocessing-market.aspx

Market Segmentation:

Based on product, the upstream bioprocessing market is segmented into cell culture products, bioreactors/fermenters, filters, bags & containers, bioreactor accessories and others. The bioreactors/fermenters segment accounted for the largest share of the market in 2020 due to its increasing demand in large as well small-scale bioproduction and development of automated bioreactors for safe, cost-effective, and regulatory-compliant manufacturing of cell-based products for clinical applications.    

North America is expected to be the highest growth over the forecast period over the forecast period due to rising investment related to research and development of new biomolecules & mAbs, increasing prevalence of chronic diseases, and availability of developed healthcare infrastructure in the region.

Key Players in the upstream bioprocessing market are Thermo Fisher Scientific, GE Healthcare, Merck, Corning, Sartorius, Eppendorf, Applikon Biotechnology, Lonza, PBS Biotech, and CellGenix.

Request Sample Pages by clicking on https://www.lucintel.com/upstream-bioprocessing-market.aspx

The report helps stakeholders understand the pulse of the market and provides them with information on key drivers, restraints, challenges, and opportunities for market growth. It would also help to understand the competitors better and gain more insights to improve their position in the business.

To read more about this market please click on https://www.lucintel.com/upstream-bioprocessing-market.aspx

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: 
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Minimally Invasive Surgical Instrument Market:

For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

 

Endoscopy Equipment Market:

For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

 

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

 

Urology Device Market:

For more details click here https://www.lucintel.com/urology-device-market.aspx

 

Gene Expression Market:

For more details click here https://www.lucintel.com/gene-expression-market.aspx


No comments:

Post a Comment